For citations:
Rudakova A.V., Gusev D.A., Uskov A.N., Shestakova I.V., Lobzin Yu.V. COST-EFFECTIVENESS OF ANTIVIRAL THERAPY IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C (GENOTYPE 1) WITH VARIOUS SEVERITY OF FIBROSIS STAGE. Journal Infectology. 2017;9(4):93-101. (In Russ.) https://doi.org/10.22625/2072-6732-2017-9-4-93-101